Skip to main content
. 2024 Nov 5;12:626. doi: 10.1186/s40359-024-02057-1

Table 2.

Demographic characteristics of the study sample (n = 35)

Smile Waitlist
Characteristic n = 23 n = 12
Age, mean (SD), years 23.5 (4.9) 21.4 (1.4) t(33) = -1.44, p = .06
Gender, n (%)
 Female 19 (82.6) 7 (58.3)
 Male 4 (17.4) 5 (41.7) Χ² (1) = 2.43, p = .12
Nationality, n (%)
 Dutch 8 (34.8) 7 (58.3)
 Other 15 (65.2) 5 (41.7) Χ² (1) = 1.79, p = .28
Relationship status, n (%)
 In a relationship 6 (26.1) 5 (41.7)
 Married or cohabitating 2 (8.7) -
 Single 15 (65.2) 7 (58.3) Χ² (2) = 1.71, p = .43
Medication, n (%)
 No medication 19 (82.6) 11 (91.7)
 Antidepressants 1 (4.3) -
 Non-psychoactive medication 1 (4.3) 1 (8.3)
 Iron supplements 2 (8.7) - Χ² (3) = 1.86, p = .60
Alcohol use, n (%)
 Yes 18 (78.3) 7 (58.3) Χ² (1) = 0.22, p = .26
 No 5 (21.8) 5 (41.7)
Insomnia Severity (ISI), mean (SD) 14.3 (3.1) 15.7 (5.4) t(33) = 0.98, p = .12
Depressive symptoms (BDI II), mean (SD) 11.9 (7.1) 11.5 (6.0) t(33) = -0.15, p = .67
Anxiety symptoms (HADS-A), mean (SD) 8.9 (3.3) 8.8 (4.7) t(33) = -0.06, p = .50
Quality of Life (Q-LES-Q), mean (SD) 54.7 (13.6) 61.2 (10.1) t(33) = 1.45, p = .37
Pre-Sleep Arousal (PSAS), mean (SD) 42.6 (8.8) 42.1 (10.6) t(33) = -0.16, p = .41
Dysfunctional Beliefs and Attitudes about Sleep (DBAS), mean (SD) 73.2 (19.8) 78.4 (20.8) t(33) = -0.47, p = .97

Note. Non-psychoactive medication: Ibuprofen n = 1; Antibiotics n = 1